Operating Profit Veränderung Datum
AbbVie USD 3.2B 914M 2023-12
Acorda Therapeutics USD -3632000 7.84M 2023-06
Amgen USD 1.27B 819M 2023-12
Arrowhead Research USD -136545000 28.22M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Biogen USD 358.9M 200.1M 2023-12
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Heron Therapeutics USD -24929000 17.47M 2023-09
Incyte USD 187.27M 27.44M 2023-12
Insmed USD -178272000 30.6M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
J&J USD 4.83B 391M 2023-12
Ligand Pharmaceuticals USD -3458000 6.54M 2023-12
Marinus Pharmaceuticals USD -31646000 207K 2023-09
Merck USD -1933000000 7.68B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Novavax USD -125632000 181.09M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Enanta Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.